Keystone Symposium on „Stromal cells in Immunity“

7-12 February, 2016 – Keystone Resort, Colorado


Keystone Symposia is launching a new topic with the meeting on “Stromal Cells in Immunity” .

The conference will be held February 7-12, 2016, at the Keystone Resort in Keystone, Colorado, jointly with a symposium on “Fibrosis: From Basic Mechanisms to Targeted Therapies”.

Burkhard Ludewig, one of the Executive Committee members of the STROMA ITN, is organizing the meeting on “Stromal cells in Immunity” together with Shannon Turley (Genentech) and Melody Swartz (University of Chicago).

The organizers describe their meetings as follows:

Within lymphoid organs, non-hematopoietic stromal cells organize and interact with leukocytes in immunologically important ways. In addition to organizing T and B cell segregation and expressing lymphocyte survival factors, stromal cells support the migration of and interactions between antigen-presenting cells and naïve T and B cells during the initiation of immune responses and influence the outcome between tolerance and immunity. Recent studies in rodents, non-human primates and humans have demonstrated that stromal cells also play instrumental roles in coordinating immune responses in non-lymphoid tissues, in inflammatory and autoimmune diseases and in chronic infection. Furthermore, stromal cells are being harnessed for therapeutic applications in a number of different clinical indications, an area that holds great promise for improving human health. Our understanding of stromal cell populations and their contributions to innate and adaptive immunity as well as immunological diseases, cancer and vaccination has grown exponentially over the past few years. This emerging field has gained enormous momentum due to highly sophisticated and in-depth efforts to dissect the fundamental biology and clinical importance of this cellular compartment. These critical advances as well as work that is on the cusp of being published or in the pipeline are the focus of this meeting.

Further information and registration:


Comments are closed.